BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 33526870)

  • 1. The transcription factor PBX3 promotes tumor cell growth through transcriptional suppression of the tumor suppressor p53.
    Li WF; Herkilini A; Tang Y; Huang P; Song GB; Miyagishi M; Kasim V; Wu SR
    Acta Pharmacol Sin; 2021 Nov; 42(11):1888-1899. PubMed ID: 33526870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Silencing Pre-B-cell leukemia homeobox 3 decreases the proliferation of human glioma cells in vitro and in vivo.
    Xu X; Cai N; Bao Z; You Y; Ji J; Liu N
    J Neurooncol; 2017 Dec; 135(3):453-463. PubMed ID: 28856521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurogenic differentiation factor 1 promotes colorectal cancer cell proliferation and tumorigenesis by suppressing the p53/p21 axis.
    Lei K; Li W; Huang C; Li Y; Alfason L; Zhao H; Miyagishi M; Wu S; Kasim V
    Cancer Sci; 2020 Jan; 111(1):175-185. PubMed ID: 31715070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibiting oncogenic signaling by sorafenib activates PUMA via GSK3β and NF-κB to suppress tumor cell growth.
    Dudgeon C; Peng R; Wang P; Sebastiani A; Yu J; Zhang L
    Oncogene; 2012 Nov; 31(46):4848-58. PubMed ID: 22286758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circular RNA circCORO1C promotes laryngeal squamous cell carcinoma progression by modulating the let-7c-5p/PBX3 axis.
    Wu Y; Zhang Y; Zheng X; Dai F; Lu Y; Dai L; Niu M; Guo H; Li W; Xue X; Bo Y; Guo Y; Qin J; Qin Y; Liu H; Zhang Y; Yang T; Li L; Zhang L; Hou R; Wen S; An C; Li H; Xu W; Gao W
    Mol Cancer; 2020 Jun; 19(1):99. PubMed ID: 32487167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Demethylase-independent function of JMJD2D as a novel antagonist of p53 to promote Liver Cancer initiation and progression.
    Li M; Deng Y; Zhuo M; Zhou H; Kong X; Xia X; Su Z; Chen Q; Guo P; Mo P; Yu C; Li W
    Theranostics; 2020; 10(19):8863-8879. PubMed ID: 32754284
    [No Abstract]   [Full Text] [Related]  

  • 7. PBX3 promotes migration and invasion of colorectal cancer cells via activation of MAPK/ERK signaling pathway.
    Han HB; Gu J; Ji DB; Li ZW; Zhang Y; Zhao W; Wang LM; Zhang ZQ
    World J Gastroenterol; 2014 Dec; 20(48):18260-70. PubMed ID: 25561793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The small molecule AU14022 promotes colorectal cancer cell death via p53-mediated G2/M-phase arrest and mitochondria-mediated apoptosis.
    Ryu H; Nam KY; Kim JS; Hwang SG; Song JY; Ahn J
    J Cell Physiol; 2018 Jun; 233(6):4666-4676. PubMed ID: 29030986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. E2F-1 transcriptional activity is a critical determinant of Mdm2 antagonist-induced apoptosis in human tumor cell lines.
    Kitagawa M; Aonuma M; Lee SH; Fukutake S; McCormick F
    Oncogene; 2008 Sep; 27(40):5303-14. PubMed ID: 18521084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative analysis of p53-targeted gene expression and visualization of p53 transcriptional activity following intratumoral administration of adenoviral p53 in vivo.
    Ohtani S; Kagawa S; Tango Y; Umeoka T; Tokunaga N; Tsunemitsu Y; Roth JA; Taya Y; Tanaka N; Fujiwara T
    Mol Cancer Ther; 2004 Jan; 3(1):93-100. PubMed ID: 14749479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pbx3 and Meis1 cooperate through multiple mechanisms to support Hox-induced murine leukemia.
    Garcia-Cuellar MP; Steger J; Füller E; Hetzner K; Slany RK
    Haematologica; 2015 Jul; 100(7):905-13. PubMed ID: 25911551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DIMP53-1: a novel small-molecule dual inhibitor of p53-MDM2/X interactions with multifunctional p53-dependent anticancer properties.
    Soares J; Espadinha M; Raimundo L; Ramos H; Gomes AS; Gomes S; Loureiro JB; Inga A; Reis F; Gomes C; Santos MMM; Saraiva L
    Mol Oncol; 2017 Jun; 11(6):612-627. PubMed ID: 28296148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mdm2 inhibition of p53 induces E2F1 transactivation via p21.
    Wunderlich M; Berberich SJ
    Oncogene; 2002 Jun; 21(28):4414-21. PubMed ID: 12080472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A single recombinant adenovirus expressing p53 and p21-targeting artificial microRNAs efficiently induces apoptosis in human cancer cells.
    Idogawa M; Sasaki Y; Suzuki H; Mita H; Imai K; Shinomura Y; Tokino T
    Clin Cancer Res; 2009 Jun; 15(11):3725-32. PubMed ID: 19458054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Indirect p53-dependent transcriptional repression of Survivin, CDC25C, and PLK1 genes requires the cyclin-dependent kinase inhibitor p21/CDKN1A and CDE/CHR promoter sites binding the DREAM complex.
    Fischer M; Quaas M; Nickel A; Engeland K
    Oncotarget; 2015 Dec; 6(39):41402-17. PubMed ID: 26595675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SNHG10/DDX54/PBX3 Feedback Loop Contributes to Gastric Cancer Cell Growth.
    Zhang Y; Guo H; Zhang H
    Dig Dis Sci; 2021 Jun; 66(6):1875-1884. PubMed ID: 32712782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-302a inhibits human HepG2 and SMMC-7721 cells proliferation and promotes apoptosis by targeting MAP3K2 and PBX3.
    Wang M; Lv G; Jiang C; Xie S; Wang G
    Sci Rep; 2019 Feb; 9(1):2032. PubMed ID: 30765768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel alternative PBX3 isoforms in leukemia cells with distinct interaction specificities.
    Milech N; Kees UR; Watt PM
    Genes Chromosomes Cancer; 2001 Nov; 32(3):275-80. PubMed ID: 11579467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Msi1 promotes tumor growth and cell proliferation by targeting cell cycle checkpoint proteins p21, p27 and p53 in cervical carcinomas.
    Liu X; Yang WT; Zheng PS
    Oncotarget; 2014 Nov; 5(21):10870-85. PubMed ID: 25362645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations of p53 and KRAS activate NF-κB to promote chemoresistance and tumorigenesis via dysregulation of cell cycle and suppression of apoptosis in lung cancer cells.
    Yang L; Zhou Y; Li Y; Zhou J; Wu Y; Cui Y; Yang G; Hong Y
    Cancer Lett; 2015 Feb; 357(2):520-6. PubMed ID: 25499080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.